In 2023, Gilmore O’Neill earned $3.24M in total compensation at Editas Medicine, including $641.09K salary, $392.54K bonus and $2.19M in stock. 3+ years at the helm of Editas Medicine.
Compensation History
Annual executive compensation data for Gilmore O’Neill, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$3.24M
Salary
$641.09K
Bonus
$392.54K
Other
$7.29K
Salary
$641.09KBoard Justification
The compensation philosophy is designed to attract and retain qualified executives, motivate them to achieve business goals, and reward them for performance. It emphasizes a significant portion of performance-based compensation.
Bonus
$392.54KBoard Justification
The annual performance-based cash bonus for Dr. O’Neill was determined solely based on the achievement of corporate goals and his target bonus amount, as determined by our Board, and pursuant to the terms of his offer letter.
Other Compensation
$7.29KBoard Justification
Other compensation includes life insurance premiums and 401(k) matching contributions.
Restricted Stock
Board Justification
The stock awards granted to Dr. O’Neill that vested in 2023 were performance-based restricted stock units (PSUs) that vest upon the achievement of certain research and development milestones.
Performance Metrics
The performance metrics for Dr. O’Neill's compensation were based on corporate performance goals, with a corporate achievement percentage of 102% for 2023.
Gilmore O’Neill
CEO of Editas Medicine
Education
Ph.D. in Biomedical Engineering from the University of California, San Diego.
Field of Expertise
Healthcare & Life Sciences - Biotechnology
Sector of Economy
Healthcare
CEO of Editas Medicine for
3 years 6 months (Jun 2022 - Present)
Previous Experience
Various leadership roles in biotechnology and healthcare.
Other Editas Medicine CEOs
Holdings
Track Gilmore O’Neill's stock holdings and portfolio value over time.
Insider Trading
Gilmore O’Neill's recent stock transactions, purchases, and sales filed with the SEC.
No insider trades found for this CEO.
Rivals
Compare Gilmore O’Neill with competitor CEOs and industry peers.